Advertisement
Advertisement
INO
Inovio Pharmaceuticals, Inc.
1.19
USDSponsored
+0.08
+7.21%
Apr 15, 15:47 UTC -4
Closed
After-Market
1.19
0.00
-0.42%
INO Earnings Reports
Positive Surprise Ratio
INO beat 19 of 41 last estimates.
46%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$252.50K
/-$0.35
Implied change from Q4 25 (Revenue/ EPS)
--
/-683.33%
Implied change from Q1 25 (Revenue/ EPS)
+288.46%
/-14.63%
Inovio Pharmaceuticals, Inc. earnings per share and revenue
On Mar 12, 2026, INO reported earnings of 0.06 USD per share (EPS) for Q4 25, beating the estimate of -0.36 USD, resulting in a 116.60% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.19% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.35 USD, with revenue projected to reach 252.50 thousand USD, implying an decrease of -683.33% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Pharvaris N.V. Ordinary Shares
Report Date
Apr 02, 2026 For Q4 25
Estimate
-$0.63
Actual
-$0.72
Surprise
-13.69%
Innate Pharma S.A. ADS
Report Date
Apr 01, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.55
Surprise
-353.80%
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
Sunshine Biopharma Inc.
Report Date
Apr 03, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.54
Surprise
-96.08%
FAQ
What were Inovio Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Inovio Pharmaceuticals, Inc. reported EPS of $0.06, beating estimates by 116.6%, and revenue of $0.00, 0% as expectations.
How did the market react to Inovio Pharmaceuticals, Inc.'s Q4 2025 earnings?
The stock price moved down -1.19%, changed from $1.68 before the earnings release to $1.66 the day after.
When is Inovio Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Inovio Pharmaceuticals, Inc.'s next earnings report?
Based on 4
analysts, Inovio Pharmaceuticals, Inc. is expected to report EPS of -$0.35 and revenue of $252.50K for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement